We have recently updated our zoster (also known as shingles) reference page.
Zoster is the reactivation of the varicella zoster virus (VZV) in people who have previously had varicella (chickenpox) infection. Zoster presents with a painful blistering rash. The most common side effect is post-herpetic neuralgia.
The updated page includes new details on eligibility for the upcoming National Immunisation Program (NIP) funding for Shingrix, commencing on 1 November 2023. The page also features commonly asked questions on zoster and Shingrix.